Cited by 740Alcohol Consumption and Health EffectsSubstance Abuse Treatment and OutcomesGlobal Public Health Policies and Epidemiology

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Global burden of alcoholic liver diseases

Open access

Rehm, Jürgen, Samokhvalov, Andriy V., Shield, Kevin D.·2013·Journal of Hepatology

DOI 10.1016/j.jhep.2013.03.007

Open this paper in CoChat — free account

Abstract

Liver diseases contribute markedly to the global burden of mortality and disease. This paper provides an overview from a global perspective of the contribution of alcohol to liver diseases. The Global Burden of Disease study methodology was used to estimate the burden of alcohol-attributable liver cirrhosis and alcohol-attributable liver cancer in 2010 as measured by deaths and disability adjusted life years (DALYs). This methodology estimates attributable fractions based on alcohol exposure distribution and relative risks associated with different levels of drinking. Globally, in 2010, alcohol-attributable liver cirrhosis was responsible for 493,300 deaths (156,900 female deaths and 336,400 male deaths) and 14,544,000 DALYs (4,112,000 DALYs for women and 10,432,000 DALYs for men), representing 0.9% (0.7% for women and 1.2% for men) of all global deaths and 0.6% (0.4% for women and 0.8% for men) of all global DALYs, and 47.9% of all liver cirrhosis deaths (46.5% for women and 48.5% for men) and 46.9% of all liver cirrhosis DALYs (44.5% for women and 47.9% for men). Alcohol-attributable liver cancer was responsible for 80,600 deaths (14,800 female deaths and 65,900 male deaths) and 2,142,000 DALYs (335,000 DALYs for women and 1,807,000 DALYs for men). The burden of alcohol-attributable liver cirrhosis and liver cancer is high and entirely preventable. Interventions to reduce alcohol consumption are recommended as a population health priority and may range from taxation increases for alcoholic beverages to increases in screening and treatment rates for alcohol use disorders.

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2013.03.007

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Global status report on noncommunicable diseases 2010.
Alwan, A. (2011) · Cited by 8,494
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Comparative quantification of health risks : global and regional burden of disease attributable to selected major risk factors
Ezzati, M., López, A. D., Rodgers, A., & Murray, C. J. L. (2004) · Cited by 3,319
Global Burden of Disease and Risk Factors
López, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T. T., & Murray, C. J. L. (2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,714
Alcohol: No Ordinary Commodity. Research and public policy
Babor, T. F., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., Grube, J. W., Hill, L., Holder, H. D., Homel, R. J., et al. (2003) · Cited by 1,718
Self-citation
Use and misuse of population attributable fractions
Rockhill, B., Newman, B., & Weinberg, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.15 · Cited by 1,683
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,658

Flagged first, then by citations

Show all 59 references

Research works printed but not linked: 1

Kehoe, 2012, Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms, Popul Health Metrics, 10, 6, 10.1186/1478-7954-10-6 · DOI · Paper page

Sorted by citations

Items 701–738 of 738

Trends in the burden of hospitalised patients with cirrhosis in Switzerland: a cross-sectional study of cirrhosis-related hospitalisations between 1998 and 2020
Favre-Bulle, T., Moradpour, D., Marques-Vidal, P. M., & Vaucher, J. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-081822 · Cited by 1
A Prospective study on Prescribing patterns of drugs used in Alcoholic Liver disease patients at Tertiary Care Hospital in Vadodara – A Observational Study
Kakadiya, J., Pandey, B., Yadav, P. P., Kumar, D., Maheshwari, R. A., Solanki, N. D., & Shukla, P. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00506
Versorgungssituation von Patient_innen mit äthyltoxischer Zirrhose in Vorbereitung auf eine Lebertransplantation
Binder, A., Fenchel, J., Lang, I., & Batra, A. (2024) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/0939-5911/a000895
Prognostic value of the neutrophil to lymphocyte ratio in the development of systemic inflammatory response syndrome and death in patients with liver cirrhosis
Рамидиновна, С. М., & Maevskaya, M. V. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-337
Genetic inhibition of nicotinamide N-methyltransferase and prevention of alcohol-associated fatty liver in humans
Wu, B., Weng, X., Pan, Y., Tian, Z., Wu, P., Shao, J., Liu, Y., Huang, R., Xu, T., & Zhou, K. (2024) · Journal of Human Genetics · doi:10.1038/s10038-024-01313-x
The Impact of Housing Insecurity on Hospitalized Patients with Diagnosis of Cirrhosis: A Comparative Analysis Using Data from the National Inpatient Sample (2016-2021)Preprint
Akambase, J. A., Ali, Y. O., & Goble, S. R. (2025) · Research Square · doi:10.21203/rs.3.rs-5758007/v1
Intermittent alcohol consumption changes the hepatocyte ploidy
Pereira, R. M., de Oliveira, T. J., Mendonça, A. R. D. A., & Mundim, F. G. L. (2025) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v23i3.59011
Optimization Approaches Using Machine Learning Techniques to Preidentification of Liver Cancer
Trivedi, K. (2025) · Information systems engineering and management · doi:10.1007/978-3-031-77296-2_8
Ethanol
Yoon, J. T., Devanney, J., & Fehnel, C. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00444-9
Challenges in Managing Recurrent Small Bowel Obstruction in a Patient With Concurrent Hepatic Dysfunction and Alcohol Use Disorder: A Multidisciplinary Approach
Sevgi, K., Enman, L., Lucero, F., & Aran, S. N. (2025) · Cureus · doi:10.7759/cureus.85139
The Impact of Yoga Intervention on Liver Health in Individuals with Alcohol Addiction: A Pre-post Intervention Study
Sharma, N., Krishna, N. R., & Barnwal, S. L. (2025) · Revista Internacional de Investigación en Adicciones · doi:10.28931/riiad.2025.347
Deep Learning Predicts Non-human Primate Drinking Category from Liver Histology
Khanal, B., Fong, C., Tella, S. M., Khadka, R., Gonazales, S. W., Grant, K. A., & Benton, M. L. (2025) · Communications in computer and information science · doi:10.1007/978-3-031-94950-0_31
Evaluating the association of social determinants of health and patient-reported outcome measures in patients with lisfranc injuries
Ebrahimi, A., Sohn, S., Shin, J., Aguirre–Acevedo, D. C., Lucaciu, A. R., Ashkani‐Esfahani, S., Bernstein, D. N., Bejarano‐Pineda, L., Guss, D., Kwon, J. Y., et al. (2025) · The Foot · doi:10.1016/j.foot.2025.102208
Care Coordination for Patients Admitted With Alcohol-Associated Liver Disease: An Assessment of Appropriate Follow-up and Treatment at Time of Discharge
Byers, I. S., Selvan, B., Henson, J. B., Niedzwiecki, D., Muir, A. J., & Garbarino, S. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100823
Additional file 1 of Epidemiological characteristics of alcohol-related liver disease in China: a systematic review and meta-analysis
Tang, Z., Ding, Y., Zhang, W., Zhang, R., Zhang, L., Wang, M., Wang, M., Chen, Y., & Wang, J. (2024) · Figshare · doi:10.6084/m9.figshare.26601268
Additional file 1 of The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database
Alkhouri, N., Almomani, A., Le, P., Payne, J. Y., Asaad, I., Sakkal, C., Vos, M., Noureddin, M., & Kumar, P. (2022) · Figshare · doi:10.6084/m9.figshare.20408689
Additional file 1 of Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy
Liu, Q., Xu, L., Wu, M., Zhou, Y., Yang, J., Huang, C., Xu, T., Li, J., & Zhang, L. (2021) · Figshare · doi:10.6084/m9.figshare.14954648
Phenome-wide study on alcohol consumption provides genetic evidence for a causal association with multiple diseases and biomarkers
Kassaw, N. A., Zhou, A., Stacey, D., Mulugeta, A., Lee, S., Burgess, S., & Hyppönen, E. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104624
Educational video modules for alcohol use disorder: A scalable tool to bridge the treatment gap in hepatology
Jin, Z.-X., & Sun, N. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i2.115378
Rôle direct du virus de l'hépatite C dans fibrogenèse hépatique et les mécanismes asociés
Florimond, A. (2014) · theses.fr (ABES) · doi:10.70675/c2b7f3f5ze748z43acza580zdebbf7edf3ac
Le microbiote intestinal comme cible thérapeutique dans la maladie alcoolique du foie : implication des acides biliaires et de la pectine
Ciocan, D. M. (2018) · theses.fr (ABES) · doi:10.70675/f76b0335zd8baz4b14za916zd8a1cbd3325c
Élastographie impulsionnelle : étude des artefacts et développement d’une méthode de guidage par ondes élastiques monochromatiques
Lorée, H. (2020) · doi:10.70675/e05fb465z3c3dz425bzaa1dz0e5b226c5630
PhotoFib - Etude par histologie spectrale du développement de la cirrhose dans des modèles murins et chez l’Homme.
Guillard, J. (2023) · theses.fr (ABES) · doi:10.70675/f98c5197z2bf3z42a9z946az3cce0b05462c
Spontaneous Recovery and Mortality in Patients With ALD Referred for Early Liver Transplantation
Hasjim, B. J., Kwong, A. J., Cheung, A. C., Cooper, K. M., Devuni, D., Mohamed, K., Roldan, G. A., Wang, K., Deutsch‐Link, S., Shroff, H., et al. (2026) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000004032
Multiomics characterization of an alcohol-induced hepatocellular carcinoma mouse model
Oh, S. H., Park, S. B., Kang, J., Shin, S., Kim, G.-Y., Bong, Y., Gu, M., Lee, Y.-S., Gao, B., & Seo, W. (2026) · Lab Animal · doi:10.1038/s41684-026-01724-7
Quality of Life, Fatigue, Resilience, Anxiety, and Depression in Patients Having Chronic Liver Disease
Sinha, A., Chaudhari, B., Chaudhury, S., & Banerjee, D. (2026) · Annals of Indian Psychiatry · doi:10.4103/aip.aip_261_25
Sociodemographic Disparities in Binge and Heavy Drinking Among U.S. Adults, 2024
Mattingly, D. T., Diaby, M., Yockey, A., & Jacobs, W. (2026) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2026.108433
IMPACTO DO CONSUMO CRÔNICO DE ÁLCOOL NA POPULAÇÃO IDOSA: ESTUDO DE SÉRIE TEMPORAL DAS HOSPITALIZAÇÕES HEPÁTICAS NO BRASIL (2010-2024)
Couto, F. S., Spörr, A. V., Ribas, V. D. A., Klein, C., Lazzari, M. L., GOBI, I. G., de Carvalho, T. S. B., Marques, F. C., Mansur, G. L., & Rocha, A. S. (2026) · International Journal of Health Management Review · doi:10.47172/ijhmreview.v12i2.489
Impact of Gene Polymorphism rs2275913 and Serum IL-17A Levels on Liver Fibrosis Severity Across the Natural History of Chronic Hepatitis B in Indonesia
Maimunah, U., Palayukan, A., Juniastuti, J., Tjokroprawiro, B. A., & Miftahussurur, M. (2026) · Diseases · doi:10.3390/diseases14070227
The Scavenger Function of LSECs, a Regulator of Liver Diseases
Zhou, J., Zhang, L., Wang, J., Zhang, C., & Tian, C. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48080802
Kava (Piper methysticum G. Forst) for Substance Use Disorders: A Review of Mechanism, Pharmacology, Clinical Evidence, and Therapeutic Potential
Krehl, J., Mamallapalli, J., Xing, C., & Grundmann, O. (2026) · Nutrients · doi:10.3390/nu18172747
Phytochemical Profiling and Preliminary Hepatoprotective Screening of Different Solvent Fractions of Elaeagnus parvifolia Fruit Extract Against Carbon Tetrachloride (CCl₄)–Induced Liver Injury in Mice
Khan, M. Z., Shoaib, M., Ahmad, M. S., Jafri, S. A. A., Malik, M. A., Ullah, Y., Azemi, A. K., Kari, Z. A., Pratama, D. A. O. A., Yasin, I. S. M., et al. (2026) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-026-00798-1
基于唾液次黄嘌呤的酒精代谢快慢表型无创分型及生物标志物研究
赵, 静., 韩, 英., Pan, Z., 罗, 禄., Min, W., 卢, 静., & 石, 亚. (2026) · 医学研究杂志 · doi:10.61654/yxyjzz2026.07.005
NEDD4L-mediated ALYREF ubiquitination degradation suppresses RUBCNL expression to impair autophagy and promote lipogenesis in alcoholic hepatic fibrosis
Hu, X., Wu, J., Huang, Y., Guo, Q., & Xie, Z. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117348
Correlation and discriminatory performance of non-invasive serum fibrosis indices according to liver disease etiology using two-dimensional shear wave elastography as reference
Galaviz-Valdez, M. E., Torres-González, L., Izaguirre-García, J. R., Alarcón-Galván, G., Moreno-Pena, D. P., Rodríguez-Rodríguez, D. R., Cura–Esquivel, I., & Cordero‐Pérez, P. (2026) · Clinics · doi:10.1016/j.clinsp.2026.101187
MORTALIDADE POR CIRROSE HEPÁTICA NO ESTADO DO PARANÁ ENTRE 2000 E 2024: ESTUDO EPIDEMIOLÓGICO
Junior, C. T., & Zanin, G. D. (2026) · Revista Saúde dos Vales · doi:10.66104/ct1hdk62
Acute Alcohol-Associated Hepatitis: The Role of Liver Transplantation
Khan, A. M., & Malik, S. M. (2026) · Journal of Intensive Care Medicine · doi:10.1177/08850666261498029
Experimental evaluation of the safety and hepato-protective activity of Raktaphaladi Vati against ethanol induced hepatotoxicity in Wister rats: an in vivo study
Dhoot, S. R., & Gangasagre, N. S. (2026) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20263711

Authors: Rehm, J., Samokhvalov, A. V., & Shield, K. D.
Affiliations: Centre for Addiction and Mental Health (CA)
ORCID: Rehm, Jürgen
Samokhvalov, Andriy V.
Shield, Kevin D.
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 2013-07
Volume: 59
Issue: 1
Pages: 160-168
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/j.jhep.2013.03.007
OpenAlex: W2048180954
Cited by: 740
References: 59
Citations by year: 2026: 25 · 2025: 47 · 2024: 42 · 2023: 53 · 2022: 67 · 2021: 61 · 2020: 89 · 2019: 76 · 2018: 74 · 2017: 73 · 2016: 50 · 2015: 55 · 2014: 23 · 2013: 4
FWCI: 6.45
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 15 d)
Locations: Journal of Hepatology (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: Ontario Ministry of Health and Long-Term Care
Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Public Health Policies and Epidemiology
Keywords: alcoholic liver disease, liver cirrhosis, liver cancer, disability-adjusted life years, alcohol consumption, attributable fraction, alcohol taxation, global burden of disease
MeSH terms: Alcohol Drinking, Female, Humans, Liver Cirrhosis, Alcoholic, Liver Diseases, Alcoholic, Liver Neoplasms, Male, Risk Factors, Sex Factors, Global Health, Quality-Adjusted Life Years

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Global burden of alcoholic liver diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks